Bullish option flow detected in Altimmune with 1,958 calls trading, 1.1x expected, and implied vol increasing almost 9 points to 88.77%. Apr-23 5 calls and Apr-23 5 puts are the most active options, with total volume in those strikes near 1,100 contracts. The Put/Call Ratio is 0.53. Earnings are expected on May 11th.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ALT:
- Altimmune Completes Enrollment in Phase 2 Clinical Trial of HepTcell™, an Immunotherapeutic for Chronic Hepatitis B
- Altimmune completes enrollment in Phase 2 trial of HepTcell
- Altimmune Appoints Former GSK Executive Catherine Angell Sohn, Pharm.D. to its Board of Directors
- Stifel argues sympathy trading not a predictor for Viking’s pending VK2735 data
- Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
